How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Standardized Library of Depression Outcome Measures

and to obtain higher degrees of followup. Additional measurements outside of the windows listed above are recommended as supplemental measures. Events of Interest Adverse Events Depression treatment-related adverse events. Use of a brief, publicly available, validated measurement tool to capture adverse events is recommended. Reported in 12-month intervals. Events of Interest Suicide Ideation & Behavior Selection of "several days," "more than half the days," or "nearly every day" option on PHQ-9 item 9 (...) Standardized Library of Depression Outcome Measures Standardized Library of Depression Outcome Measures | Effective Health Care Program Search Effective Health Care website Submit search Toggle navigation Select site to search Search Effective Health Care website Submit search Standardized Library of Depression Outcome Measures Michelle B. Leavy, M.P.H. Fang Li, MD, M.S. * OM1 On behalf of the Outcome Measures Framework (OMF) Depression Workgroup. Abstract Significant variation exists in both

2019 Effective Health Care Program (AHRQ)

122. Perinatal Depression: Preventive Interventions

risk of perinatal depression to counseling interventions. Grade: B Risk Assessment There is no accurate screening tool for identifying who is at risk of perinatal depression and who might benefit from preventive interventions. A pragmatic approach, based on the populations included in the systematic evidence review, would be to provide counseling interventions to women with 1 or more of the following risk factors: a history of depression, current depressive symptoms (that do not reach a diagnostic (...) or gestational diabetes, and complications during pregnancy (eg, preterm delivery or pregnancy loss). In addition, social factors such as low socioeconomic status, lack of social or financial support, and adolescent parenthood have also been shown to increase the risk of developing perinatal depression. However, there is no accurate screening tool for identifying women at risk of perinatal depression and who might benefit from preventive interventions. A pragmatic approach, based on the populations included

2019 U.S. Preventive Services Task Force

123. Depression Following Acute Coronary Syndrome

Physicians and approved by the Board of Directors in March 2019. The guideline was published in the American Family Physician on June 14, 2019. Key Recommendations A standardized depression screening tool (e.g. BDI-II, HADS, GDS, PHQ) should be used to screen for depression in patients who have recently experienced an acute coronary syndrome (ACS) event. In patients who screen positive for depression, further assessment should be performed to confirm the diagnosis of depression Antidepressant medication (...) Depression Following Acute Coronary Syndrome Depression Following Acute Coronary Syndrome -- Clinical Recommendation Welcome Search Search Specify your search AAFP.org Patient Care Clinical Practice Guideline Depression Following Acute Coronary Syndrome Screening and Treatment of Depression Following Acute Coronary Syndrome (Developed by the AAFP, March 2019) The guideline, Screening and Treatment of Depression Following Acute Coronary Syndrome , was developed by the American Academy of Family

2019 American Academy of Family Physicians

124. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. (Abstract)

on impaired psychosocial function in MDD.Adults aged 18-65 with moderate-to-severe MDD (n = 100) and age-, sex-, and education-matched healthy controls participated in a cross-sectional study validating the THINC-integrated tool (THINC-it), a cognitive screening tool comprised of objective and subjective measures of cognitive function. Depression severity was assessed using the Montgomery-Åsberg Depression Rating Scale and psychosocial function was assessed using the Sheehan Disability Scale (SDS (...) Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. Psychosocial impairment represents an important treatment target in major depressive disorder (MDD). The majority of patients with MDD do not regain premorbid levels of psychosocial functioning despite the resolution of core depressive symptoms. This study aimed to investigate the respective effects of cognitive function and depression severity

2017 Journal of Affective Disorders

125. Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial Full Text available with Trip Pro

Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial Depression is a highly prevalent and costly disorder. Effective treatments are available but are not always delivered to the right person at the right time, with both under- and over-treatment a problem. Up to half the patients presenting to general practice report (...) symptoms of depression, but general practitioners have no systematic way of efficiently identifying level of need and allocating treatment accordingly. Therefore, our team developed a new clinical prediction tool (CPT) to assist with this task. The CPT predicts depressive symptom severity in three months' time and based on these scores classifies individuals into three groups (minimal/mild, moderate, severe), then provides a matched treatment recommendation. This study aims to test whether using

2017 Trials Controlled trial quality: predicted high

126. Measurement, Education and Tracking in Integrated Care (METRIC): use of a culturally adapted education tool versus standard education to increase engagement in depression treatment among Hispanic patients: study protocol for a randomized control trial Full Text available with Trip Pro

Measurement, Education and Tracking in Integrated Care (METRIC): use of a culturally adapted education tool versus standard education to increase engagement in depression treatment among Hispanic patients: study protocol for a randomized control trial Significant mental health disparities exist for Hispanic populations, especially with regard to depression treatment. Stigma and poor communication between patients and their providers result in low use of antidepressant medications and early (...) in primary care settings. Recent recommendations from the U.S. Preventive Services Task Force are that primary care providers screen adult patients for depression only if systems are in place to ensure adequate treatment and follow-up.We are conducting a randomized controlled trial among 150 depressed adult Hispanics in a primary care safety net setting, testing the effectiveness of a culturally appropriate depression education intervention to reduce stigma and increase uptake in depression treatment

2017 Trials Controlled trial quality: uncertain

127. Breast screening: Hologic Affirm Prone Biopsy System

version? 1 1 1 How good was the clinical applications training for tomosynthesis/stereo core needle biopsy provided by the the supplier? 2 1 Would have liked to have seen more cases; would have liked more training with lateral arm (became available later in the evaluation) How do you rate the image handling tools for biopsy? 2 1 How do you rate the ease of using prone affirm equipment for biopsy targetting? 1 2 How do you rate the use of the display screen of the biopsy control module (touchscreen (...) Breast screening: Hologic Affirm Prone Biopsy System NHS Breast Screening Programme Equipment Report Practical Evaluation of the Hologic ® Affirm Prone Biopsy System March 2019 Practical Evaluation of the Hologic Affirm Prone Biopsy System 2 About Public Health England Public Health England exists to protect and improve the nation’s health and wellbeing, and reduce health inequalities. We do this through world-leading science, knowledge and intelligence, advocacy, partnerships and the delivery

2019 Public Health England

128. Nutrition screening and use of oral nutrition support for adults in the acute care setting

for malnutrition risk recommendations 31 3.1.4 Comparison of adapted NICE recommendations and the GDG-generated recommendation with other national guidelines, policies and reports 32 3.1.5 Comparison with other international guidelines 33 3.1.6 NICE clinical guideline adaptation considerations 34 3.1.7 Evidence to decision framework 34 3.1.8 Brief description of recommended malnutrition screening tools: 35 3.1.9 Screening for malnutrition risk and intervention care pathways 36 3.1.10 Other considerations 37 (...) -to-decision framework 117 13. Criteria for diagnosing malnutrition 122 14. HSE Food Nutrition and Hydration Policy algorithm 123 15. International Dysphagia Diet Standardisation Initiative (IDDSI) Framework 124 16. Economic assessment 125 17. Glossary of terms and abbreviations 129 References 142 Annex 1: Systematic review of nutrition screening tool for adult patients in acute hospital settings Annex 2: Clinical and cost-effectiveness of oral nutrition support interventions in hospitalised adults Annex 3

2020 National Clinical Guidelines (Ireland)

129. Unhealthy Drug Use: Screening

. The American Academy of Pediatrics recommends screening adolescents through their early 20s for substance use (including tobacco and alcohol) at every annual physical examination as well as screening adolescents who present to emergency departments or urgent care centers; report cigarette smoking; have depression, anxiety, or other mental health conditions associated with substance abuse; or exhibit school, legal, or social problems or other behavioral changes. It provides a list of screening tools (...) for drug use in adolescents. How to implement this recommendation? For adults: Ask adults about unhealthy drug use. Clinicians can ask the questions or ask their patient to share their answers on a form, computer, or tablet. There are a variety of screening tools available, such as: Brief tools (eg, NIDA [National Institute on Drug Abuse] Quick Screen, which asks 4 questions about use of alcohol, tobacco, nonmedical use of prescription drugs, and illegal drugs in the past year), which may be more

2020 U.S. Preventive Services Task Force

130. What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)?

What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? What basic tools can be used by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY (...) by any health care professional in primary care for screening of patients with long-term conditions for mental health symptoms (anxiety and depression)? The NICE guideline on depression in adults with a chronic physical health problem (1) contains a chapter on the identification of depression in people with a chronic physical health problem. This discusses various screening tools including: the Patient Health Questionnaire, the Beck Depression Inventory, the General Health Questionnaire

2012 TRIP Answers

131. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

of eye health and vision care, but do not have specialist expertise or access to specialized equipment. It does not seek to address vision screening undertaken by pro- fessional groups with specific expertise in primary vision care, such as optometrists. The screening methods considered included both self-report of vision function and objective vision testing. Self-report included structured survey and questions. For objective testing of visual acuity, although there are several tools available (...) Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings E588 CMAJ | MAY 14, 2018 | VOLUME 190 | ISSUE 19 © 2018 Joule Inc. or its licensors I mpaired vision is an important health burden in both devel- oped and developing countries, particularly among older adults. 1 The 2006 Participation and Activity Limitation Survey found that 13% of Canadians aged 75 years and older had a “see- ing limitation,” with 31% described as severe, compared

2018 CPG Infobase

132. We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain

We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain - The BMJ ---> Patients undergoing elective surgery often attend a pre-assessment clinic where suitability for surgery is determined. Patient Reported Outcome Measures (PROMs) are increasingly used to assess the quality of care delivered to NHS patients and to demonstrate health (...) gains following surgical intervention. [1] There is a body of evidence that establishes the interaction between mental health, surgical intervention, and pain, however conditions such as depression, chronic pain and anxiety are rarely prioritised at the pre-operative assessment. [2] Furthermore, current PROMs do not adequately include a psychological assessment to assess their influence on the postoperative outcome. Many patients who reach the clinic are keen for surgery, but there is a group

2018 The BMJ Blog

133. We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain

We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain We need better screening tools and outcome measures to develop meaningful predictions of post-surgical pain - The BMJ ---> Patients undergoing elective surgery often attend a pre-assessment clinic where suitability for surgery is determined. Patient Reported Outcome Measures (PROMs) are increasingly used to assess the quality of care delivered to NHS patients and to demonstrate health (...) gains following surgical intervention. [1] There is a body of evidence that establishes the interaction between mental health, surgical intervention, and pain, however conditions such as depression, chronic pain and anxiety are rarely prioritised at the pre-operative assessment. [2] Furthermore, current PROMs do not adequately include a psychological assessment to assess their influence on the postoperative outcome. Many patients who reach the clinic are keen for surgery, but there is a group

2018 The BMJ Blog

134. Guidelines for the Evaluation and Treatment of Perimenopausal Depression

of menopausal stage, assessment of co-occurring psychiatric and menopause symptoms, appreciation of the psychosocial factors common in midlife, differential diagnoses, and the use of validated screening instruments. Proven therapeutic options for depression (ie, antidepressants, psychotherapy) are the front-line treatments for perimenopausal depression. Although estrogen therapy is not approved to treat perimenopausal depression, there is evidence that it has antidepressant effects in perimenopausal women (...) is the differential diagnosis of depression during the menopausal transition? 3) What symptoms commonly co- occur with depression in midlife women? 4) What are the unique psychosocial challenges associated with the meno- pause transition that might contribute to depressive symp- toms? and, 5) What screening measures have been validated for assessing depression and depressive symptoms? Studies that were published in a peer-reviewed journal, published in the English language, and utilized a validated or standard

2018 The North American Menopause Society

135. Assessment and Interventions for Perinatal Depression

Appendix B: Best Practice Guideline Development Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127 Appendix C: Process for Systematic Review and Search Strategy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128 Appendix D: Diversity among Pregnant and Postpartum Persons with Perinatal Depression . . . . . . . . . . . . . . . . . . . 134 Appendix E: Examples of Perinatal Depression Screening Tools (...) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143 Appendix F: Examples of Perinatal Depression Assessment Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147 Appendix G: Considerations for Selecting a Perinatal Depression Screening Tool . . . . . . . . . . . . . . . . . . . . . . . . . . . 149 Appendix H: Responding to an Identified Risk of Maternal Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152 Appendix I: Edinburgh Postnatal Depression Scale

2018 Registered Nurses' Association of Ontario

136. Got Depression? I can answer that in two questions!

Got Depression? I can answer that in two questions! Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca January 15, 2018 (...) Got Depression? I can answer that in two questions! Clinical Question: What is the diagnostic accuracy of the 2-question screen for identifying depression in primary care? Bottom Line: The 2-question screen is good at ruling out (but not ruling in) depression in primary care. Up to 50% of patients will test positive and should have more thorough evaluation to confirm depression diagnosis. Whether screening alters outcomes is debatable, but the 2-question screen may be reasonable for case- finding

2018 Tools for Practice

137. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management

editor-chosen studies with the greatest impact on clinical care. This policy is a revision of the policy in Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management Amy H. Cheung , Rachel A. Zuckerbrot , Peter S. Jensen , Danielle Laraque , Ruth E.K. Stein , GLAD-PC STEERING GROUP Abstract OBJECTIVES: To update clinical practice guidelines to assist primary care (PC) in the screening and assessment of depression. In this second part of the updated (...) . , Thus, it will be necessary to identify effective methods for disseminating information and provide assistance to PC clinicians in changing practice. Researchers should build on this work by piloting and evaluating methods, tools, and strategies to facilitate the adoption of these guidelines for the management of adolescent depression in PC settings. Researchers should also explore optimal methods for helping clinicians and their clinical settings address the range of obstacles that may interfere

2018 American Academy of Pediatrics

138. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management

were screened out, leaving a total of 8 relevant articles. A full report of all the literature reviews is available on request. Results Literature Reviews Practice Preparation Once PC practices have buy-in from administrative and clinical staff to improve depression care for youth, 2 important steps are necessary. First, before practices embark on screening for or identifying youth who are at risk for depression, training in such issues as appropriate screening tools, assessment and diagnostic (...) complex or severe patients. , Identification and Assessment In 2009, after the publication of the GLAD-PC, the United States Preventive Services Task Force (USPSTF) endorsed universal adolescent depression screening in teenagers ages 12 to 18 years. This recommendation was based on evidence that there are validated depression screening tools that work in an adolescent PC population and the evidence that there are treatments that work for the identified population. , On the basis of our review to date

2018 American Academy of Pediatrics

139. Depression: Adult and Adolescent

by the individual patient. 2 Major Changes as of December 2018 New Previous Recommendations for women who are pregnant, postpartum, or currently on antidepressants and considering pregnancy are now in a separate guideline. Previously, recommendations for pregnant and postpartum women were included in this guideline. For adults, the standalone depression screening tool (PHQ-9) has been replaced by a more expansive Annual Behavioral Health Questionnaire. For adolescents, the PHQ-9A with additional screening (...) questions (ADQ) on the back page remains the recommended tool. Previously, depression screening for adults was done by a standalone PHQ-9 tool with additional depression questions on the back page. Omega-3s and SAMe are considered options for patients who are reluctant to take traditional antidepressants. Previously, omega-3s and SAMe were not recommended for treatment of depression due to insufficient evidence. Bright light therapy is now recommended as a non- pharmacologic option for depression

2017 Kaiser Permanente Clinical Guidelines

140. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care

Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care | CMAJ Main menu User menu Search Search for this keyword Search for this keyword Guideline Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Richard Birtwhistle , Kate Morissette , James A. Dickinson , Donna L. Reynolds , Marc T. Avey , Francesca Reyes Domingo , Rachel Rodin (...) of Family Medicine and Community Health Sciences (Dickinson), University of Calgary, Alta.; Dalla Lana School of Public Health and Department of Family and Community Medicine (Reynolds), University of Toronto, Ont.; Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que. KEY POINTS The Canadian Task Force on Preventive Health Care strongly recommends against screening for thyroid dysfunction in asymptomatic nonpregnant adults. Screening for thyroid dysfunction

2019 Canadian Task Force on Preventive Health Care

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>